Institute of Biomedicine and Translational Medicine, Department of Physiology, University of Tartu, 19 Ravila Street, 50411 Tartu, Estonia.
Center of Excellence for Genomics and Translational Medicine, University of Tartu, 50411 Tartu, Estonia.
Cells. 2022 Mar 18;11(6):1032. doi: 10.3390/cells11061032.
Many studies have demonstrated significant mouse-strain-specific differences in behavior and response to pathogenic and pharmacological agents. This study seeks to characterize possible differences in microglia activation and overall severity of neuroinflammation in two widely used mouse strains, C57BL/6NTac (Bl6) and 129S6/SvEvTac (129Sv), in response to acute lipopolysaccharide (LPS) administration. Locomotor activity within the open field arena revealed similar 24 h motor activity decline in both strains. Both strains also exhibited significant bodyweight loss due to LPS treatment, although it was more severe in the Bl6 strain. Furthermore, LPS induced a hypothermic response in Bl6 mice, which was not seen in 129Sv. We found that 24 h LPS challenge significantly increased the inflammatory status of microglia in 129Sv mice. On the other hand, we observed that, under physiological conditions, microglia of Bl6 seemed to be in a higher immune-alert state. Gene and protein expression analysis revealed that LPS induces a significantly stronger upregulation of MHC-I-pathway-related components in the brain of Bl6 compared to 129Sv mice. The most striking difference was detected in the olfactory bulb, where we observed significant LPS-induced upregulation of MHC-I pathway components in Bl6 mice, whereas no alterations were observed in 129Sv. We observed significant positive correlations between bodyweight decline and expressions of MHC-I components in the olfactory bulbs of Bl6 mice and the frontal cortex of 129Sv, highlighting different brain regions most affected by LPS in these strains. Our findings suggest that the brains of Bl6 mice exist in a more immunocompetent state compared to 129Sv mice.
许多研究表明,在行为和对病原体及药物的反应方面,不同品系的小鼠存在显著差异。本研究旨在描述两种广泛使用的小鼠品系(C57BL/6NTac[Bl6]和 129S6/SvEvTac[129Sv])在急性脂多糖(LPS)给药后,小胶质细胞激活和神经炎症总体严重程度方面可能存在的差异。在开放场实验中,两种品系的运动活性在 24 小时内均有相似的下降。两种品系在 LPS 处理后也出现了显著的体重减轻,尽管 Bl6 品系更为严重。此外,LPS 诱导 Bl6 小鼠出现体温过低反应,但在 129Sv 中未见。我们发现,24 小时 LPS 挑战显著增加了 129Sv 小鼠小胶质细胞的炎症状态。另一方面,我们观察到,在生理条件下,Bl6 小鼠的小胶质细胞似乎处于更高的免疫警戒状态。基因和蛋白表达分析显示,与 129Sv 小鼠相比,LPS 诱导 Bl6 小鼠大脑中 MHC-I 途径相关成分的显著上调。在嗅球中观察到最显著的差异,在 Bl6 小鼠中观察到 LPS 诱导的 MHC-I 途径成分显著上调,而在 129Sv 中未观察到。我们观察到,在 Bl6 小鼠的嗅球和 129Sv 的额皮质中,体重下降与 MHC-I 成分的表达之间存在显著的正相关,这突出了这些品系中 LPS 影响最大的不同脑区。我们的研究结果表明,与 129Sv 小鼠相比,Bl6 小鼠的大脑处于更具免疫活性的状态。